Use of the community viral load as a population-based biomarker of HIV burden

AIDS

Volumn 26, Issue 3, 2012, Pages 345-353

  Castel, Amanda D ^a   Befus, Montina ^a,b   Willis, Sarah ^a   Griffin, Angelique ^c   West, Tiffany ^c   Hader, Shannon ^c,d   Greenberg, Alan E ^a  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b Mailman School of Public Health ^*  (United States)

^c District of Columbia Department of Health   (United States)

^d Palladium Group   (United States)

Author keywords

community; HIV; prevention; surveillance; transmission; viral load

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGE; ARTICLE; CAUCASIAN; CD4 LYMPHOCYTE COUNT; COMMUNITY VIRAL LOAD; CONTROLLED STUDY; FEMALE; HEALTH INSURANCE; HISPANIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; NEGRO; POPULATION RESEARCH; POVERTY; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; SEX DIFFERENCE; TREND STUDY; UNITED STATES; VIRUS LOAD; VIRUS TRANSMISSION;

CATCHMENT AREA (HEALTH); CD4 LYMPHOCYTE COUNT; DISTRICT OF COLUMBIA; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; SOCIOECONOMIC FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; URBAN HEALTH; VIRAL LOAD;

EID: 84855339578     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32834de5fe     Document Type: Article

References (33)

1. Centers for Disease Control and Prevention. HIV prevention strategic plan through 2005. 2001 http://www.cdc.gov/hiv/resources/reports/psp/pdf/prev-strat- plan.pdf (last accessed 17 March 2011).
2. Glynn M, Rhodes P. What is really happening with HIV trends in the United States? Modeling the national epidemic. In: National HIV Prevention Conference; 2005; Atlanta, Georgia.
3. Garcia PM, Kalish LA, Pitt J, Minkoff H, Quinn TC, Burchett SK, et al. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group. N Engl J Med 1999; 341: 394-402. (Pubitemid 29362512)
4. Gray RH, Wawer MJ, Brookmeyer R, Sewankambo NK, Serwadda D, Wabwire-Mangen F, et al. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 2001; 357:1149-1153. (Pubitemid 32378686)
5. Hu DJ, Subbarao S, Vanichseni S, Mock PA, van Griensven F, Nelson R, et al. Higher viral loads and other risk factors associated with HIV-1 seroconversion during a period of high incidence among injection drug users in Bangkok. J Acquir Immune Defic Syndr 2002; 30:240-247. (Pubitemid 34664421)
6. Modjarrad K, Chamot E, Vermund SH. Impact of small reductions in plasma HIV RNA levels on the risk of heterosexual transmission and disease progression. AIDS 2008; 22:2179-2185.
7. Porco TC, Martin JN, Page-Shafer KA, Cheng A, Charlebois E, Grant RM, Osmond DH. Decline in HIV infectivity following the introduction of highly active antiretroviral therapy. AIDS 2004; 18:81-88. (Pubitemid 38402321)
8. Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire-Mangen F, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 2000; 342:921-929. (Pubitemid 30177052)
9. Hughes J, Baeten J, Lingappa J, Magaret A, Wald A, de Bruyn G, et al. Determinants of per-act infectivity of HIV-1 in the partners in prevention study. In: 18th Conference on Retroviruses and Opportunistic Infections; 2011; Boston, Massachusetts.
10. Lingappa J, Thomas K, Hughes J, Baeten J, Fife K, De Bruyn G. et al. Infected partners plasma HIV-RNA level and the HIV-1 set point of their heterosexual seroconverting partners. In: 18th Conference on Retroviruses and Opportunistic Infections; 2011; Boston, Massachusetts.
11. Montaner JS, Lima VD, Barrios R, Yip B, Wood E, Kerr T, et al. Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study. Lancet 376: 532-539.
12. Wood E, Kerr T, Marshall BD, Li K, Zhang R, Hogg RS, et al. Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study. BMJ 2009; 338:b1649.
13. Das M, Chu PL, Santos GM, Scheer S, Vittinghoff E, McFarland W, Colfax GN. Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS One; 5:e11068.
14. Office of National AIDS Policy. National HIV/AIDS strategy for the United States. Washington, DC: The White House; 2010. http://www.whitehouse.gov/ administration/eop/onap/nhas.
15. Dieffenbach CW, Fauci AS. Universal voluntary testing and treatment for prevention of HIV transmission. JAMA 2009; 301:2380-2382.
16. Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet 2009; 373:48-57.
17. Coates TJ, Richter L, Caceres C. Behavioural strategies to reduce HIV transmission: how to make them work better. Lancet 2008; 372:669-684.
18. HIV Prevention Trials Network. HPTN 065 TLC-Plus: a study to evaluate the feasibility of an enhanced test, link to care, plus treat approach for HIV prevention in the United States. 2010. http://www.hptn.org/research-studies/ hptn065.asp.
19. District of Columbia Department of Health. District of Columbia HIV/AIDS, Hepatitis, STD, and TB Epidemiology annual report update 2009 (2010). http://doh.dc.gov/doh/frames.asp?doc=/doh/lib/doh/services/administration- offices/hiv-aids/pdf/annual-report-hahsta-march-2010.pdf (last accessed 18 April 2011).
20. Joint United Nations Programme on HIV/AIDS (UNAIDS)/World Health Organization (WHO), Guidelines for second generation HIV surveillance (2000). http://whqlibdoc.who.int/hq/2000/WHO-CDS-CSR-EDC-2000.5.pdf (last accessed 4 April 2011).
21. District of Columbia Department of Health. Heterosexual relationships and HIV in Washington, DC (2008). http://doh.dc.gov/doh/frames.asp?doc=/doh/lib/ doh/pdf/dc-hiv-heterosexualstudy. pdf (last accessed 3 April 2011).
22. District of Columbia Department of Health. MSM in DC: a lifelong commitment to stay HIV free (2009). http://doh.dc.-gov/doh/frames.asp?doc=/doh/ lib/doh/services/administration-offices/hiv-aids/pdf/msm-in-dc-hahsta-behavior- study-2010.pdf (last accessed 23 May 2011).
23. Magnus M, Kuo I, Shelley K, Rawls A, Peterson J, Montanez L, et al. Risk factors driving the emergence of a generalized heterosexual HIV epidemic in Washington, District of Columbia networks at risk. AIDS 2009; 23:1277-1284.
24. District of Columbia Department of Health. District of Columbia HIV/AIDS reporting requirements (2006). http://dchealth.dc. gov/doh/frames.asp?doc=/doh/ lib/doh/services/administration-offices/hiv-aids/pdf/dc-hivaids-reporting-final- rulemaking-11-17-06.pdf (last accessed 19 August 2010).
25. United States Census Bureau. U.S. Census Bureau Estimates 2000 (2000). http://www.census.gov (last accessed 29 September 2011).
26. Laraque F, Mavronicolas H, Gortakowski H, Terzian A. Disparities in community viral load among HIV-infected persons in New York City. In: 18th Conference on Retroviruses and Opportunistic Infections; 2011; Boston, Massachusetts.
27. Castel AD, Samala R, Griffin A, West-Ojo T, Greenberg A, Rocha N, et al. Monitoring the impact of expanded HIV testing in the District of Columbia using population-based HIV/AIDS surveillance data. In: 17th Conference on Retroviruses and Opportunistic Infections; 2010; San Francisco, California.
28. Ulett KB, Willig JH, Lin HY, Routman JS, Abroms S, Allison J, et al. The therapeutic implications of timely linkage and early retention in HIV care. AIDS Patient Care STDS 2009; 23:41-49.
29. Centers for Disease Control and Prevention. Expanded HIV testing and trends in diagnoses of HIV infection: District of Columbia, 2004-2008. MMWR Morb Mortal Wkly Rep 2010; 59:737-741.
30. Oramasionwu CU, Hunter JM, Skinner J, Ryan L, Lawson KA, Brown CM, et al. Black race as a predictor of poor health outcomes among a national cohort of HIV/AIDS patients admitted to US hospitals: a cohort study. BMC Infect Dis 2009; 9:127.
31. Centers for Disease Control and Prevention. HIV prevalence, unrecognized infection, and HIV testing among men who have sex with men: five U.S. cities, June 2004-April 2005. MMWR Morb Mortal Wkly Rep 2005; 54:597-601.
32. Marks G, Crepaz N, Janssen RS. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS 2006; 20:1447-1450. (Pubitemid 43948252)
33. Graham JW. Missing data analysis: making it work in the real world. Annu Rev Psychol 2009; 60:549-576.